TP53 and triple-negative breast carcinoma: To assess the predictive value of drug-resistant proteins - serum glutathione S-transferase (GST-â), P-glycoprotein (PGP), P53, Ki-67 - in triple-negative breast cancer (TNBC) and their role in chemotherapy resistance.